{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:15:47Z","timestamp":1792271747123,"version":"4.4.0"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The oral Janus kinase (JAK) inhibitor baricitinib is approved by the U.S. Food and Drug Administration for the treatment of alopecia areata (AA). We report a case of dual improvement of AA and immune thrombocytopenia (ITP) with oral baricitinib monotherapy, which may suggest linked autoimmune pathophysiology. In phase III clinical trials of baricitinib for AA, reports of rare adverse haematological events include neutropenia and anaemia. While a history of haematological comorbidities may raise concern for many clinicians when considering treatment with a JAK inhibitor, this clinical vignette suggests that baricitinib may be considered and safely administered in those with concomitant AA and ITP. A 56-year-old man with a history of AA, ITP and vitiligo presented to the clinic for relapse of his steroid-resistant hair loss which had previously been treated with tofacitinib. In consultation with the patient\u2019s haematologist, baricitinib 2\u2005mg daily was started with close platelet monitoring then doubled to 4\u2005mg after platelets showed improvement at the 6-month follow-up. Fourteen months after initiating baricitinib, improvement in white and dark hair regrowth was observed, and platelets remained normal. Thus, baricitinib may be considered for the dual treatment of AA and ITP with regular platelet monitoring and co-management with haematology colleagues.<\/jats:p>","DOI":"10.1093\/skinhd\/vzae019","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T16:02:45Z","timestamp":1737561765000},"page":"66-69","source":"Crossref","is-referenced-by-count":2,"title":["Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report"],"prefix":"10.1093","volume":"5","author":[{"given":"Chelsea","family":"Moon","sequence":"first","affiliation":[{"name":"Keck School of Medicine, University of Southern California , Los Angeles, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E","family":"Park","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine, University of California Los Angeles , Los Angeles, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Keck School of Medicine, University of Southern California , Los Angeles, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1871-571X","authenticated-orcid":false,"given":"Katrina H","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Keck School of Medicine, University of Southern California , Los Angeles, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"2025031806242982800_vzae019-B1","doi-asserted-by":"crossref","first-page":"1243556","DOI":"10.3389\/fimmu.2023.1243556","article-title":"Inhibition of T-cell activity in alopecia areata: recent developments and new directions","volume":"14","author":"Passeron","year":"2023","journal-title":"Front Immunol"},{"key":"2025031806242982800_vzae019-B2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMoa2110343","article-title":"Two phase 3 trials of baricitinib for alopecia areata","volume":"386","author":"King","year":"2022","journal-title":"N Engl J Med"},{"key":"2025031806242982800_vzae019-B3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1525-1470.1999.99008.x","article-title":"Simultaneous onset of alopecia areata and idiopathic thrombocytopenic purpura: a potential association?","volume":"16","author":"Levin","year":"1999","journal-title":"Pediatr Dermatol"},{"key":"2025031806242982800_vzae019-B4","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/pbc.25144","article-title":"Immune thrombocytopenia and alopecia areata: spontaneous occurrence and resolution in the same patient","volume":"61","author":"Cohn","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"2025031806242982800_vzae019-B5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/0974-7753.179392","article-title":"Concurrence of immune thrombocytopenic purpura and alopecia areata: a rare association","volume":"8","author":"Salman","year":"2016","journal-title":"Int J Trichology"},{"key":"2025031806242982800_vzae019-B6","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.1111\/1346-8138.17359","article-title":"A case of alopecia areata multiplex accompanied by chronic idiopathic thrombocytopenic purpura","volume":"51","author":"Obata","year":"2024","journal-title":"J Dermatol"},{"key":"2025031806242982800_vzae019-B7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"2025031806242982800_vzae019-B8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ebiom.2015.02.015","article-title":"Reversal of alopecia areata following treatment with the JAK1\/2 inhibitor baricitinib","volume":"2","author":"Jabbari","year":"2015","journal-title":"EBioMedicine"},{"key":"2025031806242982800_vzae019-B9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1056\/NEJMcp1810479","article-title":"Immune thrombocytopenia","volume":"381","author":"Cooper","year":"2019","journal-title":"N Engl J Med"},{"key":"2025031806242982800_vzae019-B10","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2014-03-560441","article-title":"Genetic studies reveal an unexpected negative regulatory role for jak2 in thrombopoiesis","volume":"124","author":"Meyer","year":"2014","journal-title":"Blood"},{"key":"2025031806242982800_vzae019-B11","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.12998\/wjcc.v8.i24.6389","article-title":"Refractory case of ulcerative colitis with idiopathic thrombocytopenic purpura successfully treated by Janus kinase inhibitor tofacitinib: a case report","volume":"8","author":"Komeda","year":"2020","journal-title":"World J Clin Cases"},{"key":"2025031806242982800_vzae019-B12","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/ajh.27433","article-title":"Safety and efficacy of baricitinib in steroid-resistant or relapsed immune thrombocytopenia: an open-label pilot study","volume":"99","author":"Zhao","year":"2024","journal-title":"Am J Hematol"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/5\/1\/66\/61559692\/vzae019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/5\/1\/66\/61559692\/vzae019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T06:24:52Z","timestamp":1742279092000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/5\/1\/66\/7972527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3,18]]}},"URL":"https:\/\/doi.org\/10.1093\/skinhd\/vzae019","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,1,22]]}}}